Luthringer Remy
CIK 0001610384
CEODirector
Filings
5
Latest Dec 23, 2025
Issuers covered
1
Showing
5 of 5
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 0% | -49.4% | -49.4% | -40.1% | -58.8% |
| 90 days | 2 | 0% | -130.1% | -130.1% | -107.2% | -152.9% |
| 180 days | 2 | 50% | +2.5% | +2.5% | +12.2% | -7.2% |
| 365 days | 2 | 100% | +42.5% | +42.5% | +47.7% | +37.2% |
Issuers
Companies where Luthringer Remy has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| NERV | Minerva Neurosciences, Inc. | 5 | Dec 23, 2025 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|